Login Register Cart 0

Articles by Disease (Others)

Recent Advances in Particulate-induced Pulmonary Fibrosis For the Application of Possible Strategy Experimentally and Clinically

Journal: Current Drug Targets
Volume: 1
Page: 297-307
Author(s): A. A. Kim, Y. C. Park, Y. Lim and H. K. Lee

Preface

Journal: Current Medicinal Chemistry
Volume: 7
Page: i-i
Author(s): G. Dannhardt

Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition.

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1041-1062
Author(s): Xavier de Leval, Jacques Delarge, Fabian Somers, Pascal de Tullio, Yves Henrotin, Bernard Pirotte and Jean-Michel Dogne

Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1101-1112
Author(s): G. Dannhardt and S. Laufer

COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1113-1120
Author(s): C. Hoffmann

Cyclooxygenase-2 Inhibition and Side-effects of Non-steroidal Antiinflammatory Drugs in the Gastrointestinal Tract.

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1121-1129
Author(s): J. Meyer-Kirchrath and K. Schror

COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1131-1144
Author(s): B. C. Moore and D. L. Simmons

COX-2 Selectivity and Inflammatory Processes

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1145-1161
Author(s): Joanne van Ryn, Gnnter Trummlitz and Michel Pairet

Role of Cyclooxygenases in Angiogenesis

Journal: Current Medicinal Chemistry
Volume: 7
Page: 1163-1170
Author(s): K. M. Leahy, A. T. Koki and J. L. Masferrer

Preface

Journal: Current Pharmaceutical Design
Volume: 6
Page: iii-iii
Author(s): Peter M. Brooks


© 2024 Bentham Science Publishers | Privacy Policy